Clinical Trial Update: Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis [Phase 2]

View source ↗

Summary

Phase 2 trial update on VDA-1102 ointment for actinic keratosis reports efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• VDA-1102 ointment (VDA-1102)

Snippet

Sponsor: Vidac Pharma | Conditions: Actinic Keratosis | Phase 2 | Status: COMPLETED | Results posted: 2023-01-12